Under the Influence with Jo Piazza The Ozempic of it All
Nov 26, 2024
Dive into candid conversations about women's health and the impact of medications like Ozempic. Discover personal stories of navigating weight loss amidst societal pressures and the nostalgia of Thanksgiving. Explore the surprising mental clarity that comes with semi-glutide treatment, alongside discussions on food stigma and mindful eating. From tackling compulsive behaviors to advocating for change in healthcare for aging women, this dialogue emphasizes the urgency of real conversations around health and women's experiences.
AI Snips
Chapters
Transcript
Episode notes
Jo Piazza's Semiglutide Journey
- Jo Piazza shares her experience with semiglutides, prompted by constant questions and celebrity secrecy.
- She aims for honesty and open conversation, especially among women regarding health and body image.
Ozempic and the Semiglutide Market
- Ozempic is a brand name for semiglutides, originally for diabetes, but its weight loss side effect led to new versions.
- Capitalism fueled the development of semiglutides specifically for weight loss, like Wegovy and Mounjaro.
Motivations and Health Concerns
- Jo's motivations for trying semiglutides include managing a rare muscular dystrophy and wanting to fit into her clothes.
- Maintaining lean muscle becomes crucial for women as they age, but Jo was gaining weight despite exercise and dietary changes.